Deutsch
 
Hilfe Datenschutzhinweis Impressum
  DetailsucheBrowse

Datensatz

DATENSATZ AKTIONENEXPORT

Freigegeben

Zeitschriftenartikel

IP-Based Incentives Against Antimicrobial Crisis: A European Perspective

MPG-Autoren
/persons/resource/persons79145

Batista,  Pedro Henrique D.
MPI for Innovation and Competition, Max Planck Society;

/persons/resource/persons205270

Byrski,  Dennis
MPI for Innovation and Competition, Max Planck Society;

/persons/resource/persons51216

Lamping,  Matthias
MPI for Innovation and Competition, Max Planck Society;

/persons/resource/persons53776

Romandini,  Roberto
MPI for Innovation and Competition, Max Planck Society;

Externe Ressourcen
Es sind keine externen Ressourcen hinterlegt
Volltexte (beschränkter Zugriff)
Für Ihren IP-Bereich sind aktuell keine Volltexte freigegeben.
Volltexte (frei zugänglich)
Es sind keine frei zugänglichen Volltexte in PuRe verfügbar
Ergänzendes Material (frei zugänglich)
Es sind keine frei zugänglichen Ergänzenden Materialien verfügbar
Zitation

Batista, P. H. D., Byrski, D., Lamping, M., & Romandini, R. (2019). IP-Based Incentives Against Antimicrobial Crisis: A European Perspective. IIC - international review of intellectual property and competition law, 50(1), 30-76. doi:10.1007/s40319-018-00782-w.


Zitierlink: https://hdl.handle.net/21.11116/0000-0002-CB4D-4
Zusammenfassung
The field of antimicrobials is considered to be facing a crisis. Increasing
microbial resistance is creating a demand for new drugs, which however is not being
matched by privately funded R&D. The reasons for this market failure are of a
technical and economic nature. The present article analyzes what changes to IP-
based incentives are conceivable in the European Union (EU) in order to address the
antimicrobial crisis. Since the assessment of the suitability of the analyzed options
depends on interdisciplinary research, this article also proposes a research agenda to
be considered for the implementation of public policies in this field.